Article
Revolutionizing pediatric neuroblastoma treatment: unraveling new molecular targets for precision interventions
27 Mar 2024
Abstract excerpt
Neuroblastoma (NB) is the most frequent solid tumor in pediatric cases, contributing to around 15% of childhood cancer-related deaths. The wide-ranging genetic, morphological, and clinical diversity within NB complicates the success of current treatment methods. Acquiring an in-depth understanding of genetic alterations implicated in the development of NB is essential for creating safer and more efficient...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
